Dachaigh › Luchd-obrach › Nexus Pharmaceuticals Inc.
Nexus Pharmaceuticals Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Nexus Pharmaceuticals Inc. 9 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 8. Tuarastal meadhanach a chaidh a thabhann: $107,745.
A bheil Nexus Pharmaceuticals Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Nexus Pharmaceuticals Inc. 9 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 10 Dùbh 2024. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Formulation Scientist II | 3 | $93,341 |
| Analytical Scientist III | 2 | $111,628 |
| Director, Analytical Research & Development | 1 | $164,800 |
| Technical Transfer Associate | 1 | $75,000 |
| Formulation Scientist III | 1 | $105,000 |
| Lead Scientist, Formulation Development | 1 | $142,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $128,400 |
| FY2024 | 3 | $105,000 |
| FY2025 | 3 | $110,490 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Analytical Scientist III | $110,490–$120,000 Ìre IV | Lincolnshire, IL | 10 Dùbh 2024 | 11 Dùbh 2024 | Dearbhaichte |
| Formulation Scientist II | $94,682–$98,000 Ìre III | Lincolnshire, IL | 7 Samh 2024 | 17 Gearr 2025 | Dearbhaichte |
| Lead Scientist, Formulation Development | $142,000 Ìre IV | Lincolnshire, IL | 7 Dàmh 2024 | 27 Faoi 2025 | Dearbhaichte |
| Formulation Scientist III | $105,000–$115,000 Ìre IV | Lincolnshire, IL | 14 Cèit 2024 | 30 Sult 2024 | Dearbhaichte |
| Technical Transfer Associate | $75,000–$90,000 Ìre II | Lincolnshire, IL | 19 Gearr 2024 | 2 Cèit 2024 | Dearbhaichte |
| Analytical Scientist III | $112,765–$126,050 Ìre IV | Lincolnshire, IL | 7 Gearr 2024 | 27 Ògmh 2024 | Dearbhaichte |
| Formulation Scientist II | $92,000–$98,000 Ìre III | Lincolnshire, IL | 22 Sult 2023 | 8 Faoi 2024 | Dearbhaichte |
| Formulation Scientist II | $92,000–$98,000 Ìre IV | Lincolnshire, IL | 22 Sult 2023 | 8 Faoi 2024 | Air a tharraing air ais |
| Director, Analytical Research & Development | $164,800 Ìre IV | Lincolnshire, IL | 18 Cèit 2023 | 22 Ògmh 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).